Healthcare sector performed well through the early phase of Covid, and as such, returns were high in that period. What we have seen is a correction for some time post that stellar initial performance. However, even earnings performance for the larger pharma companies has been weak in the past few quarters driven by weak margins.
Subscribe To Our Free Newsletter |